In hepatocellular carcinoma, PABPC1 interacts with AGO2 to augment miRNA repression by facilitating RISC binding and enhancing miRNA-mediated deadenylation, leading to the inhibition of tumor suppressor genes [9]. Here, AGO2 is linked to hepatocellular carcinoma.